140 related articles for article (PubMed ID: 37697172)
1. A (Traditional Chinese Medicine) TCM-Inspired Doxorubicin Resistance Reversing Strategy: Preparation, Characterization, and Application of a Co-loaded pH-Sensitive Liposome.
Zhang X; Liu H; Li N; Li J; Wang M; Ren X
AAPS PharmSciTech; 2023 Sep; 24(7):181. PubMed ID: 37697172
[TBL] [Abstract][Full Text] [Related]
2. Reversal of P-glycoprotein-mediated multidrug resistance by doxorubicin and quinine co-loaded liposomes in tumor cells.
Shen Q; Qiu L
J Liposome Res; 2017 Dec; 27(4):293-301. PubMed ID: 27581212
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice.
Jin Q; Zhou X; Niu X; Ping C; Dong X; Duan D; Wang R; Chen Y; Pan F; Yang F; Yang X; Zhang G; Wang R; Zhang S; Ren G
Colloids Surf B Biointerfaces; 2024 May; 241():113992. PubMed ID: 38833960
[TBL] [Abstract][Full Text] [Related]
4. A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer.
Zhai L; Luo C; Gao H; Du S; Shi J; Wang F
Int J Nanomedicine; 2021; 16():3185-3199. PubMed ID: 34007173
[TBL] [Abstract][Full Text] [Related]
5. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
Zheng G; Zheng M; Yang B; Fu H; Li Y
Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
[TBL] [Abstract][Full Text] [Related]
6. Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer.
Gomes ER; Carvalho AT; Barbosa TC; Ferreira LL; Calado HDR; Sabino AP; Oliveira MC
AAPS PharmSciTech; 2022 Sep; 23(7):255. PubMed ID: 36109444
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
8. Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin.
Meng X; Zhang H; Chen L; Wang M; Zhang K; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2023 Feb; 24(2):64. PubMed ID: 36759405
[TBL] [Abstract][Full Text] [Related]
9. Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy.
Lei J; Cong S; Song M; Zhang W; Peng G; Li X; Liu Y
Drug Dev Ind Pharm; 2018 Apr; 44(4):570-581. PubMed ID: 29260918
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
11. Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
Sun G; Sun K; Sun J
Drug Deliv; 2021 Dec; 28(1):1132-1140. PubMed ID: 34121558
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
14. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
15. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
[TBL] [Abstract][Full Text] [Related]
16. [Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer].
Liu H; Liu Y; Li N; Zhang GQ; Wang M
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3472-3484. PubMed ID: 37474984
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Optimization of Doxorubicin and Biochanin A Combinational Liposomes for Reversal of Chemoresistance.
Dash TK; Konkimalla VB
AAPS PharmSciTech; 2017 May; 18(4):1116-1124. PubMed ID: 27600324
[TBL] [Abstract][Full Text] [Related]
18. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
19. Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer.
Ahmed KS; Liu S; Mao J; Zhang J; Qiu L
Drug Des Devel Ther; 2021; 15():3223-3239. PubMed ID: 34349500
[TBL] [Abstract][Full Text] [Related]
20. Enhanced in vitro antitumor efficacy of a polyunsaturated fatty acid-conjugated pH-responsive self-assembled ion-pairing liposome-encapsulated prodrug.
Wang Y; Fan P; Zhu L; Zhuang W; Jiang L; Zhang H; Huang H
Nanotechnology; 2020 Apr; 31(15):155101. PubMed ID: 31846941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]